← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Gamma Therapeutics, Inc.
Portland, OR
$2,057,575
Total funding
3
Grants
Funding over time
peak $520.3K · FY2010–23$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,832,575 · 2
NSF$225,000 · 1
By mechanism
R44$1,554,865 · 1
R41$277,710 · 1
—$225,000 · 1
Investigators at Gamma Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Venous Thromboembolism Risk Marker Assay$520,322
R44 · FY2011 · HL
Venous Thromboembolism Risk Marker Assay$520,320
R44 · FY2012 · HL
Venous Thromboembolism Risk Marker Assay$514,223
R44 · FY2010 · HL
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels$277,710
R41 · FY2023 · HL
STTR Phase I: Rapid Hemostatic Dressing for Hemorrhage Control$225,000
· FY2016 · TIP